AR017430A1 - Un hidrato de la sal del acido maleico de la 5[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4-diona, un proceso para su preparacion,composicion farmaceutica que lo contiene y uso del mismo para la fabricacion de un medicamento - Google Patents

Un hidrato de la sal del acido maleico de la 5[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4-diona, un proceso para su preparacion,composicion farmaceutica que lo contiene y uso del mismo para la fabricacion de un medicamento

Info

Publication number
AR017430A1
AR017430A1 ARP980106365A ARP980106365A AR017430A1 AR 017430 A1 AR017430 A1 AR 017430A1 AR P980106365 A ARP980106365 A AR P980106365A AR P980106365 A ARP980106365 A AR P980106365A AR 017430 A1 AR017430 A1 AR 017430A1
Authority
AR
Argentina
Prior art keywords
amino
methyl
manufacture
preparation
maleic acid
Prior art date
Application number
ARP980106365A
Other languages
English (en)
Spanish (es)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of AR017430A1 publication Critical patent/AR017430A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ARP980106365A 1997-12-16 1998-12-15 Un hidrato de la sal del acido maleico de la 5[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4-diona, un proceso para su preparacion,composicion farmaceutica que lo contiene y uso del mismo para la fabricacion de un medicamento AR017430A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9726568.0A GB9726568D0 (en) 1997-12-16 1997-12-16 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
AR017430A1 true AR017430A1 (es) 2001-09-05

Family

ID=10823694

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP980106365A AR017430A1 (es) 1997-12-16 1998-12-15 Un hidrato de la sal del acido maleico de la 5[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4-diona, un proceso para su preparacion,composicion farmaceutica que lo contiene y uso del mismo para la fabricacion de un medicamento
ARP980106369A AR017213A1 (es) 1997-12-16 1998-12-15 Un proceso para preparar un hidrato de la sal del acido maleico de la 5-[4-[2-(n-metil-n-(2-piridil)amino)-etoxi]bencil]tiazolidin-2,4-diona

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP980106369A AR017213A1 (es) 1997-12-16 1998-12-15 Un proceso para preparar un hidrato de la sal del acido maleico de la 5-[4-[2-(n-metil-n-(2-piridil)amino)-etoxi]bencil]tiazolidin-2,4-diona

Country Status (37)

Country Link
US (2) US7045633B2 (en:Method)
EP (1) EP1045847A1 (en:Method)
JP (1) JP2002508372A (en:Method)
KR (1) KR100549143B1 (en:Method)
CN (3) CN1281454A (en:Method)
AP (1) AP1441A (en:Method)
AR (2) AR017430A1 (en:Method)
AU (1) AU2272399A (en:Method)
BG (1) BG64905B1 (en:Method)
BR (1) BR9813604A (en:Method)
CA (1) CA2314965A1 (en:Method)
CO (1) CO4990927A1 (en:Method)
CZ (1) CZ299970B6 (en:Method)
DZ (1) DZ2680A1 (en:Method)
EA (1) EA002355B1 (en:Method)
EG (2) EG23694A (en:Method)
GB (1) GB9726568D0 (en:Method)
HR (1) HRP20000405A2 (en:Method)
HU (1) HUP0100500A3 (en:Method)
ID (1) ID24744A (en:Method)
IL (1) IL136381A (en:Method)
IN (1) IN190821B (en:Method)
MA (1) MA26582A1 (en:Method)
MY (1) MY135770A (en:Method)
NO (1) NO317253B1 (en:Method)
NZ (1) NZ504704A (en:Method)
OA (1) OA11634A (en:Method)
PE (1) PE20000057A1 (en:Method)
PL (1) PL341147A1 (en:Method)
RS (1) RS50079B (en:Method)
SK (1) SK286197B6 (en:Method)
TR (2) TR200001798T2 (en:Method)
TW (1) TW467913B (en:Method)
UA (1) UA63980C2 (en:Method)
UY (2) UY25310A1 (en:Method)
WO (1) WO1999031094A1 (en:Method)
ZA (1) ZA9811505B (en:Method)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
CA2370262A1 (en) * 1999-04-23 2000-11-02 Smithkline Beecham Plc Thiazolidinedione derivative and its use as antidiabetic
US20040248945A1 (en) 1999-04-23 2004-12-09 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
JP2002543075A (ja) * 1999-04-23 2002-12-17 スミスクライン ビーチャム パブリック リミテッド カンパニー チアゾリジンジオン誘導体および抗糖尿病薬としてのその使用
GB0014005D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
GB0021784D0 (en) * 2000-09-05 2000-10-18 Smithkline Beecham Plc Novel pharmaceutical
GB0021978D0 (en) * 2000-09-07 2000-10-25 Smithkline Beecham Plc Novel pharmaceutical
GB0129876D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
AU2002350965A1 (en) * 2001-12-13 2003-06-23 Smithkline Beecham Plc Toluenesulfonate hydrates of a thiazolidinedione derivative
AU2002352391A1 (en) * 2001-12-13 2003-06-23 Smithkline Beecham Plc A 5(-4-(2-(n-methyl-n-(2-pyridil)amino)ethoxy)benzyl)thiazolidine-2,4-dione (i) 10-camphorsulphonic acid salt and use against diabetes mellitus
AU2002352479A1 (en) * 2001-12-20 2003-07-09 Smithkline Beecham Plc 5- (4- (2- (n-methyl-n- (2-pyridyl) amino) ethoxy) benzyl) thiazolidine-2, 4-dione malic acid salt and use against diabetes mellitus
GB0130511D0 (en) * 2001-12-20 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
GB2405403A (en) * 2003-08-29 2005-03-02 Cipla Ltd Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
ITMI20041537A1 (it) * 2004-07-28 2004-10-28 Chemi Spa Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
EP2184055A1 (en) 2008-11-07 2010-05-12 LEK Pharmaceuticals d.d. Process for preparing solid dosage forms of rosiglitazone maleate

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
ATE186724T1 (de) 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
GB8820389D0 (en) * 1988-08-26 1988-09-28 Beecham Group Plc Novel compounds
GB9124513D0 (en) 1991-11-19 1992-01-08 Smithkline Beecham Plc Novel process
JPH08500835A (ja) 1992-08-28 1996-01-30 メルク エンド カンパニー インコーポレーテッド 陽イオン性−2−ヘテロアリールフェニル−カルバペネム抗菌剤
US5741803A (en) 1992-09-05 1998-04-21 Smithkline Beecham Plc Substituted thiazolidinedionle derivatives
GB9218830D0 (en) 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
TW245716B (en:Method) * 1992-12-28 1995-04-21 Takeda Pharm Industry Co
DE4404198A1 (de) 1994-02-10 1995-08-17 Henkel Kgaa 2-Fluor-6-nitroaniline
GB9726563D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
US6664278B2 (en) * 1997-12-16 2003-12-16 Smithkline Beecham P.L.C. Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
GB9726566D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
US20020137940A1 (en) 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
CZ432299A3 (cs) * 1998-06-02 2000-08-16 Smithkline Beecham Plc Kompozice obsahující 5-[4-[2-(N-methyl-N-(2- pyridyI)amino)ethoxy]benzyl]thiazolidin-2,4-dion
JP2002543075A (ja) 1999-04-23 2002-12-17 スミスクライン ビーチャム パブリック リミテッド カンパニー チアゾリジンジオン誘導体および抗糖尿病薬としてのその使用
PL351684A1 (en) 1999-04-23 2003-06-02 Smithkline Beecham Plc Polymorph of 5−[4−[2− (n−methyl−n−( 2−pyridyl)amino) ethoxy]benzyl] thiazolidine−2,4−dione, maleic acid salt
CA2370262A1 (en) 1999-04-23 2000-11-02 Smithkline Beecham Plc Thiazolidinedione derivative and its use as antidiabetic

Also Published As

Publication number Publication date
AP1441A (en) 2005-07-30
NZ504704A (en) 2003-03-28
US7045633B2 (en) 2006-05-16
CZ299970B6 (cs) 2009-01-07
GB9726568D0 (en) 1998-02-11
OA11634A (en) 2004-11-22
HUP0100500A3 (en) 2002-08-28
BR9813604A (pt) 2000-10-10
US20060189659A1 (en) 2006-08-24
EA200000655A1 (ru) 2000-12-25
KR20010033142A (ko) 2001-04-25
IN190821B (en:Method) 2003-08-23
JP2002508372A (ja) 2002-03-19
AU2272399A (en) 1999-07-05
EP1045847A1 (en) 2000-10-25
SK9102000A3 (en) 2001-01-18
CN101412713A (zh) 2009-04-22
IL136381A (en) 2003-09-17
DZ2680A1 (fr) 2005-02-20
IL136381A0 (en) 2001-06-14
US20040097553A1 (en) 2004-05-20
AP2000001830A0 (en) 2000-06-30
PE20000057A1 (es) 2000-03-09
UA63980C2 (en) 2004-02-16
TR199802626A2 (xx) 1999-10-21
NO20003068D0 (no) 2000-06-15
CZ20002205A3 (cs) 2000-11-15
BG104595A (en) 2001-02-28
EA002355B1 (ru) 2002-04-25
EG23694A (en) 2007-05-15
HRP20000405A2 (en) 2000-12-31
NO317253B1 (no) 2004-09-27
PL341147A1 (en) 2001-03-26
ID24744A (id) 2000-08-03
WO1999031094A1 (en) 1999-06-24
YU36200A (sh) 2003-12-31
AR017213A1 (es) 2001-08-22
MA26582A1 (fr) 2004-12-20
CO4990927A1 (es) 2000-12-26
HUP0100500A2 (hu) 2002-05-29
CN1281454A (zh) 2001-01-24
CA2314965A1 (en) 1999-06-24
TW467913B (en) 2001-12-11
RS50079B (sr) 2009-01-22
UY25310A1 (es) 1999-07-19
UY25305A1 (es) 2000-12-29
TR199802626A3 (tr) 1999-10-21
KR100549143B1 (ko) 2006-02-03
SK286197B6 (sk) 2008-05-06
MY135770A (en) 2008-06-30
TR200001798T2 (tr) 2000-11-21
ZA9811505B (en) 2000-11-06
NO20003068L (no) 2000-06-15
BG64905B1 (bg) 2006-08-31
EG21417A (en) 2001-10-31
CN101412714A (zh) 2009-04-22

Similar Documents

Publication Publication Date Title
AR017430A1 (es) Un hidrato de la sal del acido maleico de la 5[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4-diona, un proceso para su preparacion,composicion farmaceutica que lo contiene y uso del mismo para la fabricacion de un medicamento
UY25309A1 (es) Procedimiento para la preparación de un hidrato de un derivado de tiazolidin-2,4-diona
NO992524L (no) Konsenserte bicykliske pyrimidin-derivater
AR023564A1 (es) Una forma polimorfica de sal del acido maleico derivado del tiazolidina-2,4 diona, una composicion farmaceutica y el uso del mismo para la fabricacion deun medicamento
AR023565A1 (es) Un procedimiento para preparar una forma polimorfica de sal del acido maleico de tizazolidin-2,4 diona
UY25304A1 (es) Forma hidratada de maleato de rosiglitazona
NZ513922A (en) Composition comprising 5-Ä4-Ä2-(N-methyl-N-2-pyridyl)-amino)ethoxy!benzyl!thiazolidine-2-4-dione
EA200101101A1 (ru) Новый фармацевтический препарат
AR023563A1 (es) Monohidrato de hidrocloruro de un derivado de tiazolidin-2,4-diona, una composicion farmaceutica y el uso del mismo para la fabricacion de un medicamento
HUP9900320A2 (hu) Optikailag aktív tiazolidinonszármazékok, előállításuk, a vegyületeket hatóanyagként tartalmazó gyógyászati készítmények és tia-vagy oxazolidinonszármazékok alkalmazása gyógyászati készítmények előállítására
ECSP982779A (es) Un hidrato de la sal de acido maleico, proceso para la preparacion, composicion farmaceutica y su uso en medicina
AR017867A1 (es) Un hidrato de la sal del acido maleico de 5-4-2-(n-metil-n(2-piridil)amino)etoxi bencil tiazolidin-2,4-diona, un proceso para su preparacion, una composicion farmaceutica que lo comprende y el uso del mismo para la fabricacion de un medicamento.
TH84544A (th) ไฮเดรทชนิดใหม่
ECSP982780A (es) Nuevo producto farmaceutico proceso para su preparacion y su uso en medicina
TR200201124T2 (tr) Aromatik di-keto türevleri, üretimleri için işlemler, farmatik olarak kullanımları
ECSP003434A (es) Nuevos compuestos
ECSP003436A (es) Nuevos compuestos
TH58463A (th) สารประกอบต่อต้านเบาหวานชนิดใหม่
AR005582A1 (es) Un compuesto derivado de triazol, uso del mismo en la fabricacion de un medicamento para el tratamiento o prevención de infecciones fungicas, procedimiento y compuesto para producirlo, formulación farmaceutica que lo contiene, y un procedimiento para mejorar la solubilidad acuosa de un compuesto antifungico de triazol

Legal Events

Date Code Title Description
FC Refusal